Want to join the conversation?
For 2017, $GCO expects adjusted diluted EPS to be $4.80-4.90, up 12-14% over 2016's adjusted EPS of $4.29. These expectations do not include expected non-cash asset impairments and other charges, estimated in the range of $6.3-6.8MM pretax or $0.19-0.20 per share after tax for the full fiscal year. Comparable sales increases will be 1-2% in 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?